Influenza Update 2000

References

1. ↵
   (2000) Update: Influenza activity—United States, 1999–2000 season. MMWR 49(9):173–177, pmid:11795497.

   OpenUrlPubMed
2. ↵
   (2000) Prevention and control of influenza. Recommendations of the Advisory Committee on the Immunization Practices (ACIP). MMWR 49:1–2, (RR-3).

   OpenUrlPubMed
3. ↵
   (2000) Notices to readers. MMWR 49(27):619–622, pmid:10914929.

   OpenUrlPubMed
4. ↵
   (1998) Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 352:1877–1881, pmid:9863784.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Treanor J. J.,
   2. Vrooman P. S.,
   3. Hayden F. G.

   Efficacy of oral GS4104 in treating acute influenza [Abstract LB-4]. In: Final Program and Exhibits Addendum of the 38^th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology. 1998:21.
6. ↵
   1. Aoki F.,
   2. Osterhaus A.,
   3. Rimmelzwaan G.

   Oral GS4104 successfully reduces duration and severity of naturally acquired influenza [Abstract LB-5]. In: Final Program and Exhibits Addendum of the 38^th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology. 1998:22.
7. ↵
   1. Barker W. H.

   (1986) Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970–78. Am J Public Health 76:761–765, pmid:3717461.

   OpenUrlCrossRefPubMedWeb of Science
8. 1. Barker W. H.,
   2. Mullooly J. P.

   (1980) Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 112:798–811, pmid:7457471.

   OpenUrlPubMedWeb of Science
9. 1. Glezen W. P.

   (1982) Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 4:25–44, pmid:6754408.

   OpenUrlPubMedWeb of Science
10. 1. Guay D. R.

    (1994) Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective. Drugs Aging 5:8–19, pmid:7919641.

    OpenUrlPubMedWeb of Science
11. ↵
    1. Monto A. S.,
    2. Robinson D. P.,
    3. Herlocher M. L.

    (1999) Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 282:31–35, pmid:10404908.

    OpenUrlCrossRefPubMedWeb of Science
12. 1. Hayden F. G.,
    2. Atmar R. L.,
    3. Schilling M.

    (1999) Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 341:1336–1343, pmid:10536125.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Schilling M.,
    2. Povinelli L.,
    3. Krause P.

    (1998) Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 16:1771–1774, pmid:9778755.

    OpenUrlCrossRefPubMedWeb of Science